Related Experiment Video

Updated: Aug 7, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

The BRAF-MAPK signaling pathway is essential for cancer-immune evasion in human melanoma cells

Hidetoshi Sumimoto1, Fumie Imabayashi, Tomoko Iwata

  • 1Division of Cellular Signaling, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo 160-8582, Japan.

The Journal of Experimental Medicine
|June 28, 2006
PubMed

Insights

The activated mitogen-activated protein kinase (MAPK) pathway in BRAF-mutated melanoma promotes immune evasion. Inhibiting this pathway reduces immunosuppressive factors, making it a potential therapeutic target.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • The mitogen-activated protein kinase (MAPK) pathway is frequently activated in human cancers, contributing to malignant phenotypes.
  • BRAF mutations, specifically BRAF(V600E), are common in melanoma and lead to MAPK pathway activation.

Purpose of the Study:

  • To investigate the role of the activated MAPK pathway in immune evasion by BRAF(V600E)-mutated melanoma cells.
  • To explore the potential of targeting the MAPK pathway for overcoming melanoma immune evasion.

Main Methods:

  • Utilized MEK inhibitor U0126 and RNA interference (RNAi) targeting BRAF(V600E).
  • Assessed the production of immunosuppressive soluble factors (IL-10, VEGF, IL-6) by melanoma cells.
  • Evaluated the suppressive activity of melanoma cell supernatants on dendritic cell cytokine production (IL-12, TNF-alpha).
  • Investigated the interplay between MAPK and STAT3 signaling pathways.

Main Results:

  • Inhibition of BRAF(V600E) or MAPK signaling decreased immunosuppressive factor production by melanoma cells.
  • BRAF(V600E) RNAi reduced the suppressive activity of melanoma cell supernatants on dendritic cells.
  • No additive or synergistic effects were observed when simultaneously targeting BRAF(V600E) and STAT3.
  • Down-regulation of MAPK signaling did not affect STAT3 DNA binding or transcriptional activity.

Conclusions:

  • The activated MAPK pathway, alongside STAT3 signaling, is crucial for immune evasion in human melanomas with constitutive MAPK activation.
  • Targeting the MAPK pathway represents a potential strategy to overcome immune evasion in melanoma.

More Related Videos

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma08:18

Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma

Published on: September 8, 2021

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...